相关实验视频

Updated: Jan 16, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

为癌症免疫疗法设计一种强效的互白素-21模仿剂

Jung-Ho Chun^1,2,3, Birkley S Lim^4,5, Suyasha Roy⁶

¹Institute for Protein Design, University of Washington, Seattle, WA, USA.

Science immunology

|September 26, 2025

概括

一种新设计的IL-21模仿剂,21h10,通过增强细胞毒性T细胞和减少调节性T细胞,显示出强大的抗瘤活性,支持其在癌症免疫治疗中的翻译潜力.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
计算式蛋白质设计

背景情况:

癌症免疫疗法旨在激活细胞毒性T细胞并抑制调节性T细胞.
计算式蛋白质设计为治疗需求提供了精确的蛋白质定制.

研究的目的:

报告一个新设计的IL-21模仿器,21h10,具有增强的稳定性和信号强度.
在临床前模型中评估21h10的抗瘤活性和免疫效应.

主要方法:

一个模仿IL-21的新型蛋白质设计 (21h10).
在小鼠和ex vivo人类器官类型瘤模型中进行测试.
评估T细胞激活,细胞因子生产和调节性T细胞频率.

主要成果:

与原生IL-21相比,21h10表现出更高的稳定性,信号强度和抗瘤活性.
它有效地扩大了低亲和力细胞毒性T细胞,并增加了IFN-γ和B粒酶的表达.
21h10降低了调节性T细胞,并证明了完全的人类-小鼠交叉反应,具有可控的副作用 (胰腺炎通过TNF阻断减轻).

结论:

新设计的IL-21模拟器21h10显示了癌症免疫治疗的显著翻译潜力.
它能够激活广泛的细胞毒性T细胞,包括低亲和性T细胞,并抑制调节性T细胞的能力是有希望的.
高稳定性,功效和交叉反应性支持21h10作为一种新型癌症治疗方法的发展.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...